Oxygenation of Cervix Cancers: Impact of Clinical and Pathological Parameters

  • Michael Höckel
  • Peter Vaupel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 510)

Abstract

Current knowledge on the oxygenation status of carcinomas of the uterine cervix is mostly based on pretherapeutic data obtained in pre-and postmenopausal women. Mean and median 02 tensions (pO2) obtained from >20,000 p02-measurements in more than 400 squamous cell carcinomas of the uterine cervix observed by several research groups were, on average, distinctly lower than in normal tissues. Oxygen tensions measured in the normal cervix of nullipara patients revealed a median pO2 of 42 mmHg, whereas in conscious patients with locally advanced cancers of the cervix (stage FIGO lb-IVa), the median pO2 values were 10-20 mmHg. In patients under general propofol-anesthesia the median p02 values were 3-8 mmHg. Oxygenation status was found to be independent of various patient parameters (e.g., age, menopausal and parous state, use of oral contraceptives, smoking habits, Karnofsky index) or tumor parameters [e.g., clinical tumor size, FIGO stage, growth pattern (endophytic vs. exophytic)]2. From the studies on the oxygenation status of locally advanced cervix cancers there is also clear evidence that the pO2 distribution is extremely heterogeneous (both in space and in time) with no characteristic topological allocation of 02 partial pressures within the tumor (e.g., tumor center vs. tumor periphery). Furthermore, there was no clear correlation found between the tumor pO2 and vessel length density (“vascular density”, mm/mm): Tumor regions with low vessel length density always showed low pO2 values whereas tumor areas with higher vessel length densities can exhibit either a high or low median p02. Tumor-totumor variability in oxygenation is found to be greater than intra-tumor variability. In cervix cancers of moderately/severely anemic patients hypoxic areas are more frequently detected than in non-anemic (cHb > 12 g/dL) patients. Approximately 60% of cervical cancers contain hypoxic tissue areas with p02 values <_ 2.5 mmHg and local recurrences of cervix cancers have a higher hypoxic fraction than the primary tumors (38% vs. 25%) and lower median p02 values (4 mmHg vs. 10 mmHg).

Keywords

Adenocarcinoma Anemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. Vaupel and M. Höckel, Hypoxie beim Zervixkarzinom: Pathogenese, Charakterisierung und biologische/klinische Konsequenzen, Zentralbi. Gynakol. 123 192–197 (2001).CrossRefGoogle Scholar
  2. 2.
    M. Höckel, K. Schienger, C. Knoop, and P. Vaupel, Oxygenation of carcinomas of the uterine cervix: Evaluation by computerized 02 tension measurements, Cancer Res. 51 6098–6102 (1991).PubMedGoogle Scholar
  3. 3.
    H. Lyng, K. Sundfor, C. Trope, and E.K. Rofstad, Oxygen tension and vascular density in human cervix carcinoma, Brit J. Cancer 74, 1559–1563 (1996).PubMedCrossRefGoogle Scholar
  4. 4.
    M. Höckel, K. Schlenger, S. Höckel, B. Aral, U. Schaffer, and P. Vaupel, Tumor hypoxia in pelvic recurrences of cervical cancer, Int. J. Cancer 79, 365–369 (1998).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Höckel, C. Knoop, K. Schlenger, B. Vomdran, E. Baussmann, M. Mitze, P.G. Knapstein, and P. Vaupel, Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix, Radiother. Oncol. 26, 45–50 (1993).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Höckel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56 4509–4515 (1996).PubMedGoogle Scholar
  7. 7.
    M. Höckel and P. Vaupel, Tumor Hypoxia: Definition and current clinical, biologic, and molecular aspects, J. Nall. Cancer Inst. 93 266–276 (2001).CrossRefGoogle Scholar
  8. 8.
    A.W. Fyles, M. Milosevic, R. Wong, M.C. Kavanagh, M. Pintilie, A. Sun, W. Chapman, W. Levin, L. Manchul, T.J. Keane, and R.P. Hill, Oxygenation predicts radiation response and survival in patients with cervix cancer, Radiother. Oncol. 48 149–156 (1998).PubMedCrossRefGoogle Scholar
  9. 9.
    T.H. Knocke, H.D. Weitmann, H.J. Feldmann, E. Selzer, and R. Potter, Intratumoral p02-measurements as predictive assay in the treatment of carcinoma of the uterine cervix, Radiother. Oncol. 53 99–104 (1999).PubMedCrossRefGoogle Scholar
  10. 10.
    K. Sundfor, H. Lyng, C.G. Trope, and E.K. Rofstad, Treatment outcome in advanced squamous cell carcinoma of the uterine cervix, Radiother. Oncol. 54 101–7 (2000).PubMedCrossRefGoogle Scholar
  11. 11.
    M. Höckel, K. Schienger, S. Höckel, and P. Vaupel, Association between tumor hypoxia and malignant progression: The clinical evidence in cancer of the uterine cervix, in: Tumor Hypoxia, edited by P. Vaupel and D.K. Kelleher (Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1999).Google Scholar
  12. 12.
    M Höckel and P. Vaupel, Prognostic significance of tissue hypoxia in cervical cancer, CME J. Gynecol. Obstet. 6 216–225 (2001).Google Scholar
  13. 13.
    P. Vaupel, D.K. Kelleher, and M. Höckel, Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy, Semin. Oncol. 28 29–35 (2001).PubMedCrossRefGoogle Scholar
  14. 14.
    P. Vaupel, O. Thews, and M. Höckel, Treatment resistance of solid tumors: Role of hypoxia and anemia, Med. Oncol. in press (2001).Google Scholar
  15. 15.
    H. Lyng, K. Sundfor, and K. Rofstad. Oxygen tension in human squamous cell carcinoma and adenocarcinoma of the uterine cervix, Adv. Exp. Med. Biol. 454 635–641 (1998).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Michael Höckel
    • 1
  • Peter Vaupel
    • 2
  1. 1.Dept. Obstetrics & GynecologyUniversity of LeipzigLeipzigGermany
  2. 2.Inst. Physiology & PathophysiologyUniversity of MainzMainzGermany

Personalised recommendations